Primary lung cancer invading the chest wall.
Chest wall invasion per se does not preclude resection nor indicate incurability in patients with non-small cell lung cancer. Preoperative assessment identifies patients without evidence of distant metastases, spinal invasion, or regional lymph node metastases. At thoracotomy, these selected patients usually undergo complete resection of tumor with an expected 5-year survival, in the absence of lymph node involvement, in excess of 50% when en bloc resection of the lung and involved chest wall is performed. Neither radiotherapy nor chemotherapy appear to impact on this survival.
McCaughan
B C
BC
Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002283:Carcinoma, Bronchogenic / Q000175:diagnosis / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D010997:Pleural Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D011013:Pneumonectomy; D011300:Preoperative Care; D011379:Prognosis; D015996:Survival Rate; D013899:Thoracic Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy